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Abstract
Hyperlipidemia is a condition of abnormally high lipids levels in the blood which has been ranked as one of the greatest risk
factors contributing to prevalence and severity of coronary heart disease. The available antihyperlipidemic drugs have been
associated with some side effects however, herbal management of hyperlipidemia are relatively safe, cheap and readily available.
P. conophora is an edible plant consumed in Nigeria as snack and speculated to have beneficial effect on blood lipid profile.
The present study evaluates anti-hyperlipidemic effect of aqueous extract of cooked P. conophora nut using in vivo and in vitro
experimental models.
The anti-hyperlipidemic activity was evaluated using tyloxapol induced-hyperlipidemic rats by intraperitoneal injections of Ty-
loxapol at a dose of 300 mg/kg body weight and high cholesterol-diet induced rats by oral administration of high cholesterol diet
for 60 days. Cholesterol esterase enzyme inhibit ion was used for the in vitro evaluation.
Aqueous extract of P. conophora at varying doses, reduced the elevated lipid parameters in both models; the dose of 500
mg/kg showed comparable hypolipidemic effects with standard drug (Simvastatin) at 10 mg/kg (P<0.01). The extract also inhib-
ited cholesterol esterase enzyme with IC50 value of 129.30±0.10µg/ml wh ile Simvastatin with IC50 value of 51.42±0.13µg/ml.
Preliminary phytochemical analysis revealed the presence of; Flavonoids, saponin, cardiac glycoside, alkaloids, tannins, steroids
and reducing sugar.
P . conophora extract exhibited strong hypolipidemic activity and the dose of 500mg/kg demonstrated equipotent activity as the
standard drug; Simvastatin 10mg/kg. The extract also showed inhibitory activity against pancreatic cholesterol esterase enzyme
; hence can be used to limit absorption of dietary cholesterol, prevent and treat hyperlipidemia.
Keywords: pancreatic cholesterol esterase; Tyloxapol; High Cholesterol diet; Plukenetia conophora; Simvastatin
Introduction
Hyperlipidemia is an asymptomatic condition of abnormally el-
evated levels of any or all lipids and/or lipoprotein in the blood
*Correspondence: glory9ajayi@yahoo.com
Departments of Pharmacognosy, Faculty of pharmacy, University of
Lagos, Nigeria
Full list of author information is available at the end of the article.
and is a highly predictive risk factor for atherosclerosis, coro-
nary artery diseases and cerebral vascular diseases [1]. Hyper-
lipidemia is a global pandemic and a major risk factor for car-
diovascular disease. Cardiovascular diseases and atherosclerosis
are the most common causes of mortality and morbidity world-
wide; an approximately 12 million people reportedly die of car-
diovascular disease each year worldwide [2]. The burden of the
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disease in terms of morbidity, mortality, and medical costs is im-
mense. It is a leading cause of death for both men and women of
all races and ethnicities worldwide [3]. The prevalence of hyper-
lipidemia has dramatically increased worldwide due to modern
lifestyle and increase consumption of high fat diet [4].
The modern pharmacological therapy for the management of
hyperlipidemia is costly and associated with multiple side ef-
fects resulting in patient non-compliance and therapeutic fail-
ure. Thus, there is a need to explore alternative therapies par-
ticularly from plant sources as these are cost effective and pos-
sess minimal side effects [5]. Medicinal plants play a major role
as hypolipidemic agent; hence natural products are now part of
the current therapy for hyperlipidermia. A number of medicinal
plants have shown their beneficial effect on cardiovascular dis-
ease by virtue of their lipid lowering effect [6]. In recent times,
edible plants have increasingly become attractive alternatives to
prevent or treat various types of diseases because of easy avail-
ability and easy absorption in the body [7].
Nigerian walnut ( Plukentia conophora ) is an edible nut
widely consumed as snack in Nigeria based on speculations that
these plant products after consumption has beneficial effect on
blood lipid profile but there is little scientific proof to the effect.
It belongs to the Euphorbiaceae Family and in Nigeria; it has
various vernacular names such as asala or awusa (Yoruba), ukpa
(Ibo), oke okpokirinya (Imo) and okhue or okwe (Edo) [8, 9].
P. conophora leaves are used traditionally for curing headache
and as remedy against cancer, sexual impotence, inflammation,
antitussive, coronary heart disease [10]. The fresh nuts are used
for curing snakebites and as tonic and aphrodisiac [8].
This present work is aimed at evaluating the effect of cooked
Nigerian walnuts ( P. conophora ) aqueous extract on lipid pro-
file in hyperlipidemic-induced rat models ( in vivo ) and in vitro
cholesterol esterase inhibitory analysis.
Materials and methods
Plant collection and Preparation of Plant Extract
Plukenetia conophora (Nigerian walnut) cooked nuts were pur-
chased from Ketu market in Lagos state, Nigeria. The Plant ma-
terial was authenticated at the Department of Botany, University
of Lagos, Akoka, where a voucher specimen was deposited un-
der LUH 6941. The cooked nuts were shelled, weighed and pul-
verized with an electric blender at medium to high speed using
distilled water as solvent. It was filtered using muslin-drawstring
bags and milk-like clear filterate was obtained. The extract was
freeze dried with Lyotrap ultra freeze dryer from LTE scientific
to obtain a cream-colour semi solid oily residue, with percentage
of 12.21%.
Preliminary Phytochemical screening
Preliminary phytochemical screening of the aqueous extract of
P. conophora for various. Phytochemical classes were carried
out based on a modified version of the reported methods by
Trease and Evans, 2006; Sofowora, 1993 [11, 12]. The extract
was screened for the presence of saponins, flavonoids, tannins,
phenols, steroids, terpenoids and cardiac glycosides, reducing
sugar, alkaloids and anthraquinones.
Drugs and chemicals
Tyloxapol (Triton W 1339), p -nitrophenylbutylrate (p -NPB),
taurocholic acid sodium salt, porcine cholesterol esterase and
sodium phosphate buffer of pH (7. O) were purchased from
Sigma-Aldrich Co (Bristol scientific Co, Lagos, Nigeria), Sim-
vastatin 10mg (Teva Pharmaceutical, UK). All the other drugs
and chemicals used in this study were commercially obtained
and were of analytical grade.
Experimental animals
Adult albino rats (Wistar strain) weighing between 90-120g
were obtained from Kodak animal farm, Sango-Ota Ogun-state,
Nigeria and were kept in the animal laboratory centre under
appropriate temperature, humidity and light condition for the
study. The animals were acclimatized for two weeks under nor-
mal environmental conditions with 12 hour light/dark cycle and
sawdust for beddings. They were divided into eleven groups of
six animals each and kept in separate cages. They were fed nor-
mal rat chow and water ad libitum. Rat weight was measured
weekly with a laboratory electronic scale. The animal studies
were performed in accordance with the ethical standards laid
down by the Declaration of Helsinki and the guiding principles
in the care and use of animals [13].
In vivo experimental design
Tyloxapol – induced hyperlipidemic model
Tyloxapol – induced hyperlipidemic model reported by [14],
was followed with slight modification. Animals were divided
into five groups of six animals in each group (n = 6 per group).
Blood was collected from all the animals by ocular puncture to
obtain their baseline lipid profile. Hyperlipidemia was induced
experimentally in 12 h-fasted rats by a single intraperitoneal in-
jection of Tyloxapol (Triton WR-1339) 300 mg/kg body weight
dissolved in 0.9% normal saline. Twenty four hours after admin-
istration of Tyloxapol, blood was collected from all the animals
by occular puncture. They were used for further investigation
and treatment.
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High fat diet induced hyperlipidemic model High fat diet- in-
duced hyperlipidemic model was studied using the method de-
scribed by [15] with slight modifications. The animals were di-
vided into five groups of six animals in each group. Blood was
collected from all the animals by ocular puncture to obtain their
baseline lipid profile after overnight fasting. Hyperlipidemia was
induced by given high fat diet (egg yolk in coconut oil) orally by
gavage for 60 days. The high fat diet was prepared using half
boiled egg yolk (50g) made into paste by meshing in a mortar
and gradually adding coconut oil up to 100mls (0.5g/ml). The
paste was prepared in situ and 1ml was administered to the ani-
mal daily using oral cannula for 60 days.
Drug Treatment and Animal Groups A concentration of
100mg/ml of the P. conophora aqueous extract was prepared by
dissolving 2g (2000mg) of the extract in 19.6 mLs of distilled
water using 2% tween 80 (0.4mls) as the suspending agent. A
concentration of 2mg/ml was also prepared for the standard
drug, simvastatin by dissolving 10mg of the powdered tablet in
5ml of distilled water. The eleventh group of rats (Group 6) for
each of the experiment was the normal control, which received
distilled water and normal rat chow throughout.
Tyloxapol-induced hyperlipidemic rats were treated for a
period of 7 days as follows :
Group 1: received aqueous extract of P. conophora
125mg/kg body weight orally.
Group 2: received aqueous extract of P. conophora
250mg/kg body weight orally.
Group 3: received aqueous extract of P. conophora
500mg/kg body weight orally.
Group 4: received standard drug, simvastatin 10mg/kg body
weight orally.
Group 5: served as negative control and received no drug
treatment.
Group 6: served as normal control, received distilled water
and normal rat chow throughout
High-fat-diet- induced hyperlipidemic rats were treated
for a period of 15 days as follows:
Group 1: received aqueous extract of P. conophora
125mg/kg body weight orally.
Group 2: received aqueous extract of P. conophora
250mg/kg body weight orally.
Group 3: received aqueous extract of P. conophora
500mg/kg body weight orally.
Group 4: received standard drug, simvastatin 10mg/kg body
weight orally.
Group 5: served as negative control and received no drug
treatment
Group 6: served as normal control, received distilled water
and normal rat chow throughout
Biochemical assay Blood was collected by occular puncture
in heparinized bottle and centrifuged at 3000 rpm for 10min
at room temperature to get the serum. Serum total cholesterol,
triglyceride, HDL-C and LDL-C was estimated using Auto-
mated Analyzer at the Central Research Laboratory (APIN Lab-
oratory), Lagos university teaching hospital, Idi-araba, Lagos.
In vitro Cholesterol esterase Enzyme Inhibitory Activity:
Pancreatic cholesterol esterase inhibitory activity of the aqueous
extract of P.conophora was determined according to the method
reported by [16].
The inhibitory activity was evaluated and performed in
the presence of sodium taurocholate (TC) with p-nitrophenyl
butyrate (pNPB) as chromogenic substrate. Stock solution
of porcine cholesterol esterase (19.5ng/ml) and taurocholate
(12mM) were prepared by using 100mM sodium phosphate
buffer of pH (7. O). Stock solution of pNPB (200µM) and var-
ious concentrations (20, 40, 80 and 160µg/ml) of the aqueous
extract of P. conophora and standard drug, simvastatin were
prepared by using Acetonitrile (6%). A final volume of 1ml was
taken into a cuvette containing 430µl of assay buffer, 500µl of
TC solution, 40µl of acetonitrile, 10µl of pNPB solution and
10 µl of the inhibitor (extract or standard drug) solution were
added and thoroughly mixed. The mixture was incubated for
2 min at 25◦C and the reaction was initiated by adding 10µl
of the enzyme solution. Uninhibited enzyme activity (Blank)
was determined by adding acetonitrile instead of the inhibitor
solution (extract or standard drug). Absorbance was measured
at 405 nm. The percentage inhibition was calculated by using
method of [17].
Cholesterol esterase inhibition percentage, I = [1- a] x 100
a= enzyme activity with inhibitor /enzyme activity without
inhibitor
Statistical analysis
All data were expressed as means ± standard error of mean
(SEM) and Inhibitory concentration (IC50 ) values were calcu-
lated from plots of log concentration of inhibitor versus percent-
age inhibition curves by using Graph pad prism version 5.0 soft-
ware
The statistical parameter applied was student’s t-test and one-
way ANOVA (Analysis of variance) followed by Dunnett’s post
– hoc multiple comparison tests.
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All the statistical analysis were performed using GraphPad
Prism software version 5.0
Confidence limit was chosen at 95% (P<0.05), 99 % (P<0.01)
and 99.99% (P<0.001) P<0.05 =Significant P<0.01= Very sig-
nificant P<0.001= extremely significant P>0.05= Insignificant n
= 6
Results and discussion
Hyperlipidemia has been documented as one of the major risk
factors involved in the development of cardiovascular diseases.
Evidence from lipid lowering trials has clearly established that
reduction of total cholesterol or LDL-C is associated with a de-
creased risk of atherosclerosis and coronary heart disease [18].
High cost of synthetic antihyperlipidemic drugs and the lag on
the desired properties of safety on long term use affect patient’s
compliance [19]. Hence, natural products have become the best
alternative strategy for the development of safe, effective, af-
fordable and acceptable antihyperlipidemic agent. A number of
medicinal plants have shown their beneficial effect on cardiovas-
cular disease by virtue of their lipid lowering effects [20].
The present study was designed to verify the claimed antihy-
perlipidemic activity and investigate the possible mode of action
of the lipid-lowering effect of P. conophora nut using different
models. Intraperitoneal injection of tyloxapol is known to block
the uptake of lipoprotein from the blood circulation by extra hep-
atic tissues, resulting in an increase in the level of circulatory
lipoproteins [21].
The induction of hyperlipidemia by Tyloxapol interperitoneal
injection of 300mg/kg in this study proved to be effective in the
animals, peaking 72 hours after application of the drug. A sta-
tistical significant increase (P<0.01) in LDL-C, Triglyceride and
total cholesterol was observed compared to baseline in the in-
duced animal and significant decrease (P<0.05) was observed in
the HDL-C [22] stated that the large increase in plasma choles-
terol and triglycerides due to Tyloxapol administration resulted
mostly from an increase of VLDL secretion by the liver, accom-
panied by a strong reduction of VLDL and LDL-C catabolism.
Following the administration of varying doses of aqueous ex-
tract of P. conophora nut on the tyloxapol-induced hyperlipi-
demic rats for a period of 7days; the dose of 250mg/kg and
500mg/kg exhibited a significant decrease (P<0.05) in the ele-
vated levels of serum total cholesterol and LDL-C as well as
significant rise in the HDL-C, suggesting a beneficial modula-
tory influence on cholesterol metabolism and turnover. The dose
of 500mg/kg of P. conophora aqueous extract displayed com-
parable hypolipidemic effect with the standard drug simvastatin
10mg/kg. The serum lipid level of normal control group, nega-
tive control group and treated groups are shown in table 2.
Feeding the animals with high cholesterol diet for 60 days
resulted in significant elevation of serum TC, TG and LDL-C
concentration (P<0.01) and decrease in HDL-C (P<0.05) com-
pared to baseline measurement, this is in line with previous find-
ings reported by [23]; who demonstrated that feeding Wistar
rats a high cholesterol diet for 60 days induced hyperlipidemia.
There was also significant increase in the body weights of rats
on high fat diet compared to normal control group. The effect of
P. conophora extract on the induced hyperlipidemic rats and the
results are shown in Table 3. P. conophora dose of 250mg/kg sig-
nificantly reduce TC and LDL-C (P<0.01) and increased HDL-
C (P<0.05) while P. conophora dose of 500mg/kg significantly
reduce TG, TC and LDL-C (P<0.001) and increased HDL-C
(P<0.05) similarly as the standard drug Simvastatin 10mg/kg.
Reduction of plasma total cholesterol in response to treatment
with the aqueous extract of P. conophora was observed to be as-
sociated with the significant decrease of its LDL-C, which in
fact, is the target of several hypolipidemic drugs. This result
suggests that the cholesterol lowering activity of P.conophora
could possibly be due to a rapid catabolism of LDL-C through
its hepatic receptors for its final elimination in the form of bile
acids [24].
In general, pancreatic cholesterol esterase plays an important
role in hydrolyzing dietary cholesterol esters which liberates free
cholesterol in the lumen of the small intestine [25]. It enhances
the incorporation of cholesterol into mixed micelles and aids
transport of free cholesterol to the enterocyte [26]. Inhibitors of
Cholesterol esterase is expected to limit the bioavailability of
dietary cholesterol derived from cholesterol esters and limit the
absorption of free cholesterol.
The in vitro cholesterol esterase inhibitory activity of P.
conophora aqueous extract was examined (Table 4) and the in-
hibitory effect of the extract against bovine pancreatic choles-
terol esterase showed good activity comparable with that of the
standard drug used, simvastatin. Extract exhibited good Choles-
terol esterase activity ranging from 36.08 to 72.40% inhibiton
(for 20 to 160µg/ml) with IC50 value of 129.30±0.10µg/ml.
However, they were less potent in comparison to correspond-
ing values of the standard, Simvastatin with IC50 value of
51.42±0.13µg/ml. Similar results have been reported by [10];
that safflower and senna extracts demonstrated a potent in-
hibitory activity against pancreatic cholesterol esterase with the
IC50 values of (1.70±0.15) and (2.57±0.21) mg/mL respec-
tively.
The preliminary phytochemical investigations of the aque-
ous extract of P. conophora revealed the presence of alkaloids,
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flavonoids, steroids, saponins, cardiac glycosides, reducing sug-
ars and tannins (Table 1). This is consistent with various report
documented on the qualitative and quantitative analysis of P.
conophora nuts [27, 28].
Plant sterols are known to exert hypolipidemic effect by in-
hibiting intestinal cholesterol absorption. There is also emerging
evidence that they interfere with transport-mediated processes of
cholesterol uptake. The consequence of all these action results in
reduced cholesterol absorption and more cholesterol excretion in
faeces [29]. It has been demonstrated that plant sterol in clinical
trials block absorption sites in human, hence helped to reduce
cholesterol in human [30].
Cholesterol esterase inhibitory activity can be attributed to the
presence of flavonoids in the extract. Flavonoids have been re-
ported to irreversibly bind with the cholesterol esterase enzyme
in its active fatty acid pocket at Serine 194. It was also suggested
that the flavonoids act as suicide substrates ahead of cholesterol
esters [31]. CEase inhibitory activity can be attributed to the
presence of flavonoids in the P. conophora extract.
It has been recently reported that reduction of cholesterol ab-
sorption is a new target site of intervention for treatment of hy-
perlipidemia and obesity [32]
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All value are expres sed as Mean ± SD. Tyloxapol con-
trol group was compa red with normal control, Tyloxapol+ P.
conophora extract and drug treated groups were compared with
the Tyloxapol control group * **P<0.001, **P<0.01, *P<0.05,
ns P>0.05
All value are expres sed as Mean ± SD. HCD control group
was compa red with normal control, HCD + P. conophora extract
and standard drug treated grou ps were compared with the HCD
control group ***P<0.001, **P<0.01, *P<0.05, ns P>0.05
Table 2 Effect ofP. conophora extracts on Total Cholesterol,











































































The result of the present study showed that aqueous extract of P.
conophora have strong hypolipidemic activity against diet- in-
duced hyperlipidemia and tyloxapol-induced hyperlipidemia by
improving the serum lipid profile in the hyperlipidemic rats. P.
conophora extract showed good activity in inhibiting the enzyme
cholesterol esterase at varied potencies.
Concentration of 250mg/kg and 500mg/kg of aqueous extract
of Plukenetia conophora are effective but 500mg/kg showed
higher activity equipotent to the standard drug (Simvastatin
10mg/kg). Probable mechanisms of action of P.conophora
extracts include; decrease intestinal absorption of cholesterol
through enzyme inhibitions and also rapid catabolism of LDL-C
through its hepatic receptors for its final elimination in the form
of bile acids.
This study validates the ethnomedicinal use of P. conophora
for its hypolipidemic effect and provides platform to further
studies and research.
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Table 3 Effect of P. conophora extracts on Total Cholesterol, Triglycerides, LDL-C and HDL-C in High-Cholesterol-diet-model rats
Groups HDL-C (mmol/L) LDL-C (mmol/L) TC (mmol/L) TG (mmol /L)
Group 1 (HCD + P. conophora 125mg/kg 1.23 ± 0.09âA˛£s 0.96 ± 0.05** 4.06 ± 0.23âA˛£s 1.76 ±0.07âA˛£s
Group 2 (HCD + P. conophora 250mg/kg 1.25 ± 0.05âA˛£s 1.15 ± 0.08âA˛£s 3.62 ± 0.33* 1.31 ± 0.08**
Group 3 (HCD + P. conophora 500mg/kg 1.24 ± 0.05âA˛£s 0.89 ± 0.16*** 2.93 ± 0.03*** 1.41 ± 0.07*
Group 4 (HCD + Simvastatin 10mg/kg) 1.37 ± 0.13* 0.75 ±0.11***. 2.93 ± 0.08*** 1.41 ± 0.20*
Group 5 (HCD control) 0.98 ± 0.07 âA˛£s 1.54 ± 0.09 *** 4.57 ± 0.17 *** 1.90 ± 0.08 ***
Group 6 (Normal control) 1.19 ± 0.07 0.34 ± 0.03 2.11 ± 0.06 1.15 ± 0.04
Table 4 In vitro Pancreatic Cholesterol E sterase inhibition by
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